Pharmacy Benefits Management Services

United States Department of Veterans Affairs

PBM Home

Clinical Guidance

Abbreviated Reviews
Clinical Recommendations
Criteria for Use
Drug Class Reviews
Drug Monitoring
Drug Monographs
FAQ Sheets
Permission and Referencing PBM-MAP Documents
Pocket Cards
Therapeutic Interchange Guidance
VA National Clinical Practice Guidelines

Drug Prices, Contracts & Agreements

DoD Prices
Drug Pharmaceutical Prices
Prime Vendor Prices

Education

Distance Learning Broadcast and other Educational Opportunities
Mentor Certification Program
VA Pharmacy Residency Program
VA Learning Opportunities Residency (VALOR)

Links & Other Resources

National Formulary
Ez Minutes Newsletter
Formulary Principles Coalition (pdf)
Related Links

VA Center for Medication Safety - PSCI

About Us
Bulletins and News Alerts
Medication Safety In Seconds Newsletter
Drug Safety Features
Adverse Event Tracking Tools
Resources
Other VA Safety Projects
PGY2 Residency in Medication Safety and Outcomes Assessment
Prescription Safety

Link to JD Powers 2012 Customer Service Excellence Award

VA Center for Medication Safety - A Patient Safety Center for Inquiry

Other VA Safety Projects

A. Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer

1. Abstract

2. Table

If you have a question pertaining to this website and only information contained in this website, please contact the PBM Webmaster. Please note: For questions pertaining to Health Care Benefits, please visit http://www.vba.va.gov/VBA/ . For questions pertaining to prescription renewal, please visit http://www.myhealth.va.gov/ . Questions pertaining to your drug therapy or other medical questions should be referred directly to your Health Care Providers located at the VA facilities where you receive care.